Clinical trial matching can help a community oncology practice identify a research opportunity worth exploring for a patient. Yet finding a potentially relevant study is only one part of the process. The referral may introduce another institution, research coordinator, specialist, and set of appointments. It can also raise practical questions about who will communicate with the patient, how the referring oncologist will receive updates, and what happens if the patient does not enroll.
For community practices, these questions are part of a broader clinical trial referral follow-up process. Identifying a trial does not establish how participating physicians will coordinate care afterward, so communication expectations may need to be discussed alongside the referral itself.
A defined process can help participating teams clarify responsibilities, establish communication points, and coordinate relevant updates while defining the roles of physicians across community and academic settings.
Why Referral Planning Extends Beyond Trial Matching
Trial matching, referral, screening, enrollment, and ongoing care are distinct stages. A patient may be referred for an initial evaluation and later learn that the study is not a suitable option. Another patient may meet preliminary criteria but decide not to participate. Someone who enrolls may receive trial-specific care at a separate institution while maintaining contact with their community oncology practice, depending on the arrangements.
Each scenario can create different coordination needs. If the referring practice does not know whether an evaluation occurred or how to request relevant updates, the team may have limited information for its next conversation with the patient. The receiving team may also be unclear about what the community oncologist expects to hear.
A clearly defined oncology referral workflow can help teams address these questions as they plan the referral process. The purpose is to establish who will communicate, what information is relevant, and which next steps require discussion.
Start With Clear Roles Before the Referral
A referral process is easier to coordinate when the participating teams have discussed their responsibilities. A community oncologist, academic specialist, trial investigator, and research coordinator may have different roles. Those roles depend on the study protocol, patient circumstances, institutional policies, and the agreement between the participating organizations.
Before a referral moves forward, the referring and receiving teams can clarify several practical points:
- Who is the primary contact for questions about referral status?
- Which team will communicate screening or eligibility updates, where appropriate?
- What information may be shared, and through which approved channels?
- Who should the patient contact with questions about trial-specific procedures?
- How should the teams coordinate if the patient does not enroll or the care plan changes?
These questions are not a substitute for clinical judgment or institutional procedures. They help establish a shared understanding of the communication process. Where responsibilities are already defined by a study or organizational policy, the workflow should follow those requirements rather than create a conflicting process.
Organize the Case Information Before Handoff
Case preparation is another part of referral coordination. Relevant clinical information may include the diagnosis, treatment history, pathology, imaging summaries, prior therapies, available molecular findings, and the clinical question prompting specialist or trial review. The information required will depend on the case and the receiving team’s needs.
When information is incomplete or difficult to locate, additional exchanges may be needed before a physician discussion. Structured preparation can help identify available records, missing information, and questions that need clarification.
Case Prep extends beyond clinical trial matching. Organizing relevant case information can support specialist discussions, curbside consults, Roundtables, and other physician-to-physician conversations. Trial matching is one component of this broader case-preparation process.
For community practices, the value of preparation lies in creating a clear starting point for collaboration. It does not establish trial eligibility or replace the receiving site’s screening process. Eligibility and enrollment decisions remain subject to the trial’s criteria and the appropriate clinical evaluation.
Define What Follow-Through Means for the Practice
“Follow-through” can mean different things to different teams. For one practice, it may mean confirming that a referral was received. For another, it may include learning whether the patient attended an initial consultation, whether the trial team requested additional records, or whether the patient made a decision about participation.
Practices can define follow-through checkpoints that fit their workflow, such as referral receipt, initial evaluation, next-step discussions, and a planned transition back to community care when appropriate.
Referral pathways can differ. A patient may need more time to consider an option, the receiving team may need additional information, or the study may not be appropriate after a fuller review. The process should allow for these possibilities without assuming that enrollment is the intended or expected outcome.
A defined follow-through approach also helps distinguish administrative tracking from clinical decision-making. Staff can help coordinate communication and document status according to practice policy, while clinical questions remain with the responsible physicians and research team.
Create Communication Points, Not Unnecessary Meetings
Communication does not necessarily require a meeting. Depending on the case, a brief update, a documented message, or a focused physician discussion may be sufficient. The appropriate method depends on the question, urgency, privacy requirements, and institutional procedures.
Participating teams should understand how to connect when questions arise. For example, an academic specialist may need treatment-history details, a research coordinator may request additional records, or the receiving physician may have an update relevant to the broader care plan.
A community oncology care coordination process can identify these communication points while allowing each participant to remain focused on defined responsibilities. It can also clarify which topics belong with the research team and which should be discussed with the patient’s treating physician.
Patient communication matters as well. Patients should receive understandable information about whom to contact for trial-specific questions and how their existing care team may remain involved. The process should respect patient preferences, applicable privacy requirements, and the roles of the participating clinicians.
Plan for Different Referral Outcomes
A workflow focused on enrollment may leave other referral outcomes unaddressed. The patient may decide against the trial, may not meet eligibility criteria, or may need to consider other options with their treating physician. A study may also be unavailable by the time the patient is evaluated.
The community practice and receiving team can define how referral outcomes and next steps will be communicated, following the permissions, responsibilities, and procedures that apply to the case.
If the patient does not enroll, the community oncologist may need to discuss the next steps in the broader treatment plan. If the patient enrolls, the physicians may need to clarify which team is responsible for trial-specific care and how relevant updates will be handled. If participation later ends, the teams may need to discuss a transition plan where appropriate.
Planning for multiple outcomes makes the process more realistic. It also prevents trial matching from being treated as the final measure of whether the referral process was complete.
Use Shared Care to Connect Participating Teams
A shared-care model provides a framework for coordination across oncology settings. Participating clinicians can clarify their respective responsibilities, areas of overlap, and processes for communicating relevant information.
For example, an academic institution may be responsible for trial-related procedures while the community oncologist remains involved in appropriate aspects of the patient’s broader oncology care. The arrangement depends on the study, patient circumstances, and agreements between the teams.
Shared care provides a framework for collaboration beyond the initial referral. Physicians can use agreed communication channels to discuss questions that require additional expertise and revisit responsibilities when the patient’s care needs change.
This approach keeps the emphasis on coordination rather than transferring the patient’s broader care to a single institution. It also recognizes that a patient’s preferences and the clinical circumstances may change over time.
How 1104Health Fits Into Referral Follow-Through
1104Health’s Oncology Collaboration Network supports professional connections between community oncologists, academic specialists, and other participating physicians. Through Case Prep, Curbside Consults, Roundtables, and shared-care coordination, it provides a framework for organizing case information, discussing relevant questions, and clarifying communication across participating settings. Clinical trial matching is one component of this broader collaboration approach.
The specific follow-through process depends on the patient’s circumstances, study requirements, institutional procedures, and the responsibilities agreed upon by participating teams. The network supports professional connections without determining enrollment decisions or replacing clinical judgment.
Build a Practical Follow-Through Checklist
A practice-specific checklist can help translate referral follow-through into a manageable workflow. It may cover the intended referral destination, the appropriate contact, authorized status updates, outstanding information, and the agreed next step. The checklist should follow the practice’s procedures, privacy requirements, and arrangements with the receiving institution. Its purpose is to clarify responsibilities, not to create administrative tasks that do not support coordination.
Before referral, the practice can identify the clinical question, organize available case information, confirm the intended destination, and clarify the appropriate contact. After the referral, the team can track the status that it is authorized to track and determine whether additional communication is needed.
The checklist can also record the agreed next step. That may involve waiting for the receiving team’s response, gathering additional records, scheduling a discussion, or arranging a conversation with the patient and treating physician. The process should leave room for uncertainty when eligibility or the patient’s decision is not yet known.
Conclusion
Clinical trial referral follow-up involves more than identifying a potential study. Community oncology practices can plan for different referral outcomes by organizing case information, clarifying responsibilities, and defining how relevant updates will be communicated.
1104Health’s Oncology Collaboration Network brings Case Prep, care coordination, and physician collaboration across community and academic settings into a broader shared-care framework. These capabilities support professional coordination around a referral, while enrollment decisions and clinical care planning remain with the patient and responsible clinicians.
Frequently Asked Questions
1. What is clinical trial referral follow-up?
Clinical trial referral follow-up refers to the communication and coordination that may take place after a patient is referred for trial consideration. Depending on the situation, this can include confirming referral status, clarifying next steps, and coordinating relevant information between participating care teams.
2. Why should community oncology practices plan for what happens after a referral?
A referral can involve additional physicians, research staff, appointments, and eligibility reviews. Clarifying communication points and responsibilities can help the practice understand what follow-up may be needed, including when a patient does not enroll.
3. Does a trial referral mean the patient has transferred their broader care?
Arrangements vary by referral. The trial site may manage trial-specific responsibilities while the community oncologist remains involved in appropriate aspects of the broader care plan. The arrangement depends on clinical responsibilities, patient circumstances, study requirements, and participating organizations.
4. What information may be needed before a referral?
Depending on the case and receiving team’s requirements, relevant information may include diagnosis, treatment history, pathology, imaging, prior therapies, and the clinical question for review. The receiving team determines what is required for its evaluation.
5. How can Case Prep support physician collaboration?
Case Prep can help organize relevant case information and questions before a physician discussion. It can support trial consideration, specialist consultations, Curbside Consults, and broader case collaboration without being limited to trial matching.
6. What if the patient is not eligible for the trial?
The receiving team and community oncologist can clarify how the outcome will be communicated, subject to applicable policies and permissions. The treating physician can then discuss appropriate next steps with the patient based on the clinical circumstances.
7. What role does shared care play after a referral?
Shared care provides a framework for communication between physicians involved in different aspects of a patient’s care. It can help clarify responsibilities and information exchange when care spans community and academic settings.
8. How does 1104Health relate to trial referral follow-through?
1104Health’s broader approach includes Case Prep, care coordination, and an Oncology Collaboration Network that connects physicians across care settings. These elements support the wider collaboration process surrounding a referral rather than treating trial matching as the only task.
